2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Arnason, J. E.; Lunning, M. A.; Solomon, S. R.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K. J.; Dehner, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • HIV malignancies: From despair to gene therapy
    Meeting Abstract

    Noy, A.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • MSK-IMPACT Heme: Validation and clinical experience of a comprehensive molecular profiling platform for hematologic malignancies
    Meeting Abstract

    Ptashkin, R. N.; Benayed, R.; Ziegler, J.; Rema, A. B.; Sadowska, J.; Kiecka, I.; Ho, C.; Yao, J. J.; Moung, C.; Petrova-Drus, K.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1/2a LYM1002 study of ibrutinib (ibr) + nivolumab (nivo): Exome and gene expression profiling (GEP) analyses by histology and responder status
    Meeting Abstract

    Hodkinson, B.; Schaffer, M.; Brody, J.; Jurczak, W.; Carpio, C.; Ben-Yehuda, D.; Avivi, I.; Saleem, R.; Ozcan, M.; Alvarez, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Cost of disease progression in patients with metastatic breast, lung, and colorectal cancer
    Journal Article

    Reyes, C.; Engel-Nitz, N. M.; DaCosta Byfield, S.; Ravelo, A.; Ogale, S.; Bancroft, T.; Anderson, A.; Chen, M.; Matasar, M.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Cost of disease progression in patients with chronic lymphocytic leukemia, acute myeloid leukemia, and non‐Hodgkin's lymphoma
    Journal Article

    Reyes, C.; Engel-Nitz, N. M.; DaCosta Byfield, S.; Ravelo, A.; Ogale, S.; Bancroft, T.; Anderson, A.; Chen, M.; Matasar, M.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Lymphocyte-to-monocyte ratio may serve as a better prognostic indicator than tumor-associated macrophages in DLBCL treated with rituximab
    Journal Article

    Matsuki, E.; Bohn, O. L.; El Jamal, S.; Pichardo, J. D.; Zelenetz, A. D.; Younes, A.; Teruya-Feldstein, J.
    Applied Immunohistochemistry & Molecular Morphology (2019)

    Fulltext@MSK | Save
  • Glutamine independence is a selectable feature of pluripotent stem cells
    Research Letter

    Vardhana, S. A.; Arnold, P. K.; Rosen, B. P.; Chen, Y.; Carey, B. W.; Huangfu, D.; Carmona-Fontaine, C.; Thompson, C. B.; Finley, L. W. S.
    Nature Metabolism (2019)

    Fulltext@MSK | Save
  • Reply to M. Skelin et al
    Correspondence

    Wilson, W. H.; Staudt, L.; Younes, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save